The UALCAN online tool confirmed that SYNGR2 protein levels were significantly upregulated in LIHC, GBM, HNSCC, UCEC, LUAD, COAD, RCC, and OV (Fig. 2F). Here, SYNGR2 is linked to renal cell carcinoma.